Circulaya

The pharmaceutical industry is undergoing a significant shift in its approach to packaging, particularly in the use of polyvinyl chloride (PVC) for over-the-counter (OTC) medicine packaging. Traditionally, PVC has been a staple in pharmaceutical packaging due to its protective properties, thermoformability, and cost-effectiveness. However, growing environmental concerns and recycling challenges are driving the industry to explore more sustainable alternatives.

Traditional Role of PVC in Pharmaceutical Packaging

PVC has been widely used in blister packs, bottles, and other packaging formats for medicinal products. Its popularity stems from its ability to provide an effective barrier against dust, moisture, light, and oxygen, which are critical for maintaining the integrity and efficacy of pharmaceutical products. Additionally, PVC’s relatively low cost has made it an attractive option for manufacturers.

Environmental Concerns and Recycling Difficulties

Despite its benefits, PVC presents several environmental issues:

• Chemical and Compound Elements: PVC contains chlorine, dioxins, and furans, which can release harmful substances when incinerated.
• Additives: Plasticizers and stabilizers used in PVC can leach into the environment.
• Recycling Challenges: PVC is difficult to recycle and often contaminates other plastic waste streams.

These factors have led to increased pressure from regulators, consumers, and environmental groups to find alternative packaging solutions.

The Move Towards Alternative Materials

The pharmaceutical industry in the UK and Europe is exploring several alternatives to PVC:

• Polyethylene Terephthalate (PET): Offers good barrier properties and is widely recyclable.
• Polypropylene (PP): Provides durability and chemical resistance, making it suitable for various packaging applications.
• Polyester (PE): Offers versatility in pharmaceutical packaging, providing a balance of strength, flexibility, and moisture resistance, which is particularly useful for blister packs and sachets.
• Mono-material Solutions: Packaging made from a single type of plastic can be easier to recycle.

Challenges in Moving Away from PVC

While the industry recognizes the need for change, the transition presents several challenges:

• Regulatory Compliance: New packaging must meet stringent health and safety standards.
• Cost Considerations: Alternative materials may be more expensive, impacting product pricing.
• Manufacturing Processes: Adapting production lines for new materials requires investment and time.
• Machinery Upgrades: Additional costs are required to upgrade machinery to process new materials.
• Reduced Operational Efficiency: Switching to non-PVC materials can double the time it takes to pack the product.

Research and Innovation

Current research is focusing on developing sustainable packaging solutions that maintain the necessary protective properties. Efforts include:

• Packaging Derived from Renewable Resources: Exploring bio-based materials.
• Enhanced Recyclability: Improving recycling technologies.
• Smart Packaging Innovation: Designing new packaging to reduce material usage while maintaining product integrity.

Regulatory Landscape

In the UK and Europe, regulations are evolving to address environmental concerns. The European Union’s Circular Economy Action Plan emphasizes the need for all packaging to be reusable or recyclable by 2030. The UK Plastics Pact aims to eliminate problematic plastics and increase the use of recycled content in packaging. These regulatory frameworks are driving the pharmaceutical industry to reassess its packaging strategies and invest in more sustainable alternatives.

Duncan Flack, CiPPPA Chairman, notes, “The challenges presented by OTC packaging are numerous and wide-ranging. CiPPPA is coordinating the collective ambitions of a large proportion of the OTC and pharmaceutical industries with the aim of launching nationwide take-back and recycling schemes that could improve the end-of-life of OTC packaging formats like blister packs.”

As research continues and regulations evolve, the coming years are likely to see further innovations in sustainable pharmaceutical packaging.